866-997-4948(US-Canada Toll Free)

Global Antibacterial Drug Resistance Market Research Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 120 Pages

Notes:
Production, means the output of Antibacterial Drug Resistance
Revenue, means the sales value of Antibacterial Drug Resistance

This report studies Antibacterial Drug Resistance in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
AAIPharma Services
ANTABIO
Abgentis
Abbott Laboratories
Absynth Biologics
Achaogen
Acino Holdings
Aventis Pharma
Austell Laboratories
Assembly Biosciences
Arpida
Demuris
Evolva Holding
ContraFect
Cerexa
GSK
InterMune
Isis Pharmaceuticals
Lyndra
Microbecide
Morphochem
Nabriva Therapeutics
NanoSafe Coatings
Novexel
Osel
PENDOPHARM
Pfizer
VenatoRx Pharmaceuticals
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Antibacterial Drug Resistance in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Telavancin (Vibativ?)
Ceftaroline Fosamil (Teflaro? / Zinforo)
Fidaxomicin (Dificid / Dificlir?)
Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
Dalbavancin (Dalvance? / Xydalba?)
Tedizolid Phosphate (Sivextro?)
Oritavancin (Orbactiv? / Nuvocid?)
Ceftolozane-Tazobactam (Zerbaxa?)
Ceftazidime-Avibactam (Avycaz? / Zavicefta)
PHASE III DRUGS
Split by application, this report focuses on consumption, market share and growth rate of Antibacterial Drug Resistance in each application, can be divided into
Gram-Positive
Gram-Negative

Table of Contents

Global Antibacterial Drug Resistance Market Research Report 2017
1 Antibacterial Drug Resistance Market Overview
1.1 Product Overview and Scope of Antibacterial Drug Resistance
1.2 Antibacterial Drug Resistance Segment by Type
1.2.1 Global Production Market Share of Antibacterial Drug Resistance by Type in 2015
1.2.2 Telavancin (Vibativ?)
1.2.3 Ceftaroline Fosamil (Teflaro? / Zinforo)
1.2.4 Fidaxomicin (Dificid / Dificlir?)
1.2.5 Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
1.2.6 Dalbavancin (Dalvance? / Xydalba?)
1.2.7 Tedizolid Phosphate (Sivextro?)
1.2.8 Oritavancin (Orbactiv? / Nuvocid?)
1.2.9 Ceftolozane-Tazobactam (Zerbaxa?)
1.2.10 Ceftazidime-Avibactam (Avycaz? / Zavicefta)
1.2.11 PHASE III DRUGS
1.3 Antibacterial Drug Resistance Segment by Application
1.3.1 Antibacterial Drug Resistance Consumption Market Share by Application in 2015
1.3.2 Gram-Positive
1.3.3 Gram-Negative
1.4 Antibacterial Drug Resistance Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Antibacterial Drug Resistance (2012-2022)

2 Global Antibacterial Drug Resistance Market Competition by Manufacturers
2.1 Global Antibacterial Drug Resistance Production and Share by Manufacturers (2015 and 2016)
2.2 Global Antibacterial Drug Resistance Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Antibacterial Drug Resistance Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Antibacterial Drug Resistance Manufacturing Base Distribution, Sales Area and Product Type
2.5 Antibacterial Drug Resistance Market Competitive Situation and Trends
2.5.1 Antibacterial Drug Resistance Market Concentration Rate
2.5.2 Antibacterial Drug Resistance Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Antibacterial Drug Resistance Production, Revenue (Value) by Region (2012-2017)
3.1 Global Antibacterial Drug Resistance Production and Market Share by Region (2012-2017)
3.2 Global Antibacterial Drug Resistance Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Antibacterial Drug Resistance Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global Antibacterial Drug Resistance Consumption by Regions (2012-2017)
4.2 North America Antibacterial Drug Resistance Production, Consumption, Export, Import (2012-2017)
4.3 Europe Antibacterial Drug Resistance Production, Consumption, Export, Import (2012-2017)
4.4 China Antibacterial Drug Resistance Production, Consumption, Export, Import (2012-2017)
4.5 Japan Antibacterial Drug Resistance Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Antibacterial Drug Resistance Production, Consumption, Export, Import (2012-2017)
4.7 India Antibacterial Drug Resistance Production, Consumption, Export, Import (2012-2017)

5 Global Antibacterial Drug Resistance Production, Revenue (Value), Price Trend by Type
5.1 Global Antibacterial Drug Resistance Production and Market Share by Type (2012-2017)
5.2 Global Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
5.3 Global Antibacterial Drug Resistance Price by Type (2012-2017)
5.4 Global Antibacterial Drug Resistance Production Growth by Type (2012-2017)

6 Global Antibacterial Drug Resistance Market Analysis by Application
6.1 Global Antibacterial Drug Resistance Consumption and Market Share by Application (2012-2017)
6.2 Global Antibacterial Drug Resistance Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Antibacterial Drug Resistance Manufacturers Profiles/Analysis
7.1 AAIPharma Services
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Antibacterial Drug Resistance Product Type, Application and Specification
7.1.2.1 Telavancin (Vibativ?)
7.1.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
7.1.3 AAIPharma Services Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 ANTABIO
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Antibacterial Drug Resistance Product Type, Application and Specification
7.2.2.1 Telavancin (Vibativ?)
7.2.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
7.2.3 ANTABIO Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Abgentis
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Antibacterial Drug Resistance Product Type, Application and Specification
7.3.2.1 Telavancin (Vibativ?)
7.3.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
7.3.3 Abgentis Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Abbott Laboratories
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Antibacterial Drug Resistance Product Type, Application and Specification
7.4.2.1 Telavancin (Vibativ?)
7.4.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
7.4.3 Abbott Laboratories Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Absynth Biologics
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Antibacterial Drug Resistance Product Type, Application and Specification
7.5.2.1 Telavancin (Vibativ?)
7.5.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
7.5.3 Absynth Biologics Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Achaogen
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Antibacterial Drug Resistance Product Type, Application and Specification
7.6.2.1 Telavancin (Vibativ?)
7.6.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
7.6.3 Achaogen Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Acino Holdings
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Antibacterial Drug Resistance Product Type, Application and Specification
7.7.2.1 Telavancin (Vibativ?)
7.7.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
7.7.3 Acino Holdings Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Aventis Pharma
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Antibacterial Drug Resistance Product Type, Application and Specification
7.8.2.1 Telavancin (Vibativ?)
7.8.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
7.8.3 Aventis Pharma Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Austell Laboratories
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Antibacterial Drug Resistance Product Type, Application and Specification
7.9.2.1 Telavancin (Vibativ?)
7.9.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
7.9.3 Austell Laboratories Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Assembly Biosciences
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Antibacterial Drug Resistance Product Type, Application and Specification
7.10.2.1 Telavancin (Vibativ?)
7.10.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
7.10.3 Assembly Biosciences Antibacterial Drug Resistance Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Arpida
7.12 Demuris
7.13 Evolva Holding
7.14 ContraFect
7.15 Cerexa
7.16 GSK
7.17 InterMune
7.18 Isis Pharmaceuticals
7.19 Lyndra
7.20 Microbecide
7.21 Morphochem
7.22 Nabriva Therapeutics
7.23 NanoSafe Coatings
7.24 Novexel
7.25 Osel
7.26 PENDOPHARM
7.27 Pfizer
7.28 VenatoRx Pharmaceuticals

8 Antibacterial Drug Resistance Manufacturing Cost Analysis
8.1 Antibacterial Drug Resistance Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antibacterial Drug Resistance

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Antibacterial Drug Resistance Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Antibacterial Drug Resistance Market Forecast (2017-2022)
12.1 Global Antibacterial Drug Resistance Production, Revenue and Price Forecast (2017-2022)
12.1.1 Global Antibacterial Drug Resistance Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Antibacterial Drug Resistance Price and Trend Forecast (2017-2022)
12.2 Global Antibacterial Drug Resistance Production, Consumption , Import and Export Forecast by Regions (2017-2022)
12.2.1 North America Antibacterial Drug Resistance Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Antibacterial Drug Resistance Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Antibacterial Drug Resistance Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Antibacterial Drug Resistance Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Antibacterial Drug Resistance Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Antibacterial Drug Resistance Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Antibacterial Drug Resistance Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Antibacterial Drug Resistance Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *